For example, by modifying E-selectin on the surface of nanoparticles, Qi et al. exploited the affinity binding of E-selectin and leukocytes to achieve the nanoparticles hitchhiking with leukocytes, and thereby enabling indirect tumor targeting [91]. This evidence concerns the gene SELE and neoplasm.